ALLENS PHARMACY LIMITED

Company Registration Number:
NI633410 (Northern Ireland)

Unaudited abridged accounts for the year ended 31 December 2025

Period of accounts

Start date: 01 January 2025

End date: 31 December 2025

ALLENS PHARMACY LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2025

Balance sheet
Notes

ALLENS PHARMACY LIMITED

Balance sheet

As at 31 December 2025


Notes
2025
2024


£
£
Fixed assets
Tangible assets: 3 148,080 152,432
Total fixed assets: 148,080 152,432
Current assets
Stocks: 308,850 270,000
Debtors:   202,150 193,030
Cash at bank and in hand: 193,149 285,867
Total current assets: 704,149 748,897
Creditors: amounts falling due within one year:   (423,248) (510,019)
Net current assets (liabilities): 280,901 238,878
Total assets less current liabilities: 428,981 391,310
Total net assets (liabilities): 428,981 391,310
Capital and reserves
Called up share capital: 2 2
Profit and loss account: 428,979 391,308
Shareholders funds: 428,981 391,310

The notes form part of these financial statements

ALLENS PHARMACY LIMITED

Balance sheet statements

For the year ending 31 December 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 24 September 2026
and signed on behalf of the board by:

Name: Darren Allen
Status: Director

The notes form part of these financial statements

ALLENS PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

ALLENS PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

2. Employees

2025 2024
Average number of employees during the period 21 21

ALLENS PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

3. Tangible Assets

Total
Cost £
At 01 January 2025 404,286
Additions 904
At 31 December 2025 405,190
Depreciation
At 01 January 2025 251,854
Charge for year 5,256
At 31 December 2025 257,110
Net book value
At 31 December 2025 148,080
At 31 December 2024 152,432